Cargando…

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator

PURPOSE: A pre-biopsy decision aid is needed to counsel men with a clinical suspicion for clinically significant prostate cancer (csPCa), despite normal prostate magnetic resonance imaging (MRI). METHODS: A risk calculator (RC) for csPCa (International Society of Urological Pathology grade group (IS...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Riel, Luigi A.M.J.G., Jager, Auke, Meijer, Dennie, Postema, Arnoud W., Smit, Ruth S., Vis, André N., de Reijke, Theo M., Beerlage, Harrie P., Oddens, Jorg R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Current Best Practice for Prostate Biopsy: What is the evidence?
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958520/ https://www.ncbi.nlm.nih.gov/pubmed/35356754 http://dx.doi.org/10.1177/17562872221088536

Ejemplares similares

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

Hundred years of transperineal prostate biopsy
por: Schmeusser, Benjamin, et al.
Publicado: (2022)

Schema and cancer detection rates for transperineal prostate biopsy templates: a review
por: Sidana, Abhinav, et al.
Publicado: (2022)

A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer
por: Greenberg, Jacob W., et al.
Publicado: (2022)

Role of multi-parametric magnetic resonance imaging fusion biopsy in active surveillance of prostate cancer: a systematic review
por: Ellis, Elizabeth E., et al.
Publicado: (2022)

Multiparametric ultrasound of prostate: role in prostate cancer diagnosis
por: Kaneko, Masatomo, et al.
Publicado: (2022)

Biomarkers for prostate cancer detection and risk stratification
por: Farha, Mark W., et al.
Publicado: (2022)

Integration of magnetic resonance imaging into prostate cancer nomograms
por: Brinkley, Garrett J., et al.
Publicado: (2022)

Role of molecular imaging in the detection of localized prostate cancer
por: Galgano, Samuel J., et al.
Publicado: (2022)

Radiogenomics influence on the future of prostate cancer risk stratification
por: Banerjee, Vinayak, et al.
Publicado: (2022)

A review of artificial intelligence in prostate cancer detection on imaging
por: Bhattacharya, Indrani, et al.
Publicado: (2022)

Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2023)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Clinical Trial Protocol: Developing an Image Classification Algorithm for Prostate Cancer Diagnosis on Three-dimensional Multiparametric Transrectal Ultrasound
por: Jager, Auke, et al.
Publicado: (2023)

The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings—Implications for the COVID-19 era
por: Savin, Ziv, et al.
Publicado: (2021)

Corrigendum to “Clinical Trial Protocol: Developing an Image Classification Algorithm for Prostate Cancer Diagnosis on Three-dimensional Multiparametric Transrectal Ultrasound” [Eur. Urol. Open Sci. 49 (2023) 32–43]
por: Jager, Auke, et al.
Publicado: (2023)

Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy
por: Connor, Martin J., et al.
Publicado: (2020)

Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study)
por: Woo, Henry H., et al.
Publicado: (2022)

Prostate Cancer Risk Inflation as a Consequence of Image-targeted Biopsy of the Prostate: A Computer Simulation Study
por: Robertson, Nicola L., et al.
Publicado: (2014)

An Magnetic Resonance Imaging–directed Targeted-plus-perilesional Biopsy Approach for Prostate Cancer Diagnosis: “Less Is More”
por: Hagens, Marinus J., et al.
Publicado: (2022)

Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy
por: Örtegren, Joakim, et al.
Publicado: (2022)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

Quantification of bleeding volume using computed tomography and clinical complications after percutaneous renal biopsy
por: Chikamatsu, Yoichiro, et al.
Publicado: (2017)

Trends of renal diseases in Germany: review of a regional renal biopsy database from 1990 to 2013
por: Zink, Corinna M, et al.
Publicado: (2019)

Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI
por: Gayet, Maudy C. W., et al.
Publicado: (2020)

Kidney Biopsy Corner: Amyloidosis
por: Biederman, Laura E., et al.
Publicado: (2023)

External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort
por: Chandra Engel, Jan, et al.
Publicado: (2022)

Partial-gland Cryoablation Outcomes for Localized Prostate Cancer in Patients with Magnetic Resonance Imaging (MRI)-visible and MRI-invisible Lesions
por: Zhu, Alec, et al.
Publicado: (2023)

Predicting long-term renal and patient survival by clinicopathological features in elderly patients undergoing a renal biopsy in a UK cohort
por: Navaratnarajah, Arunraj, et al.
Publicado: (2019)

Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Reassessment of Prostate Biopsy Specimens for Patients Referred for Robot-assisted Radical Prostatectomy Rarely Influences Surgical Planning
por: Hoekstra, Robert J., et al.
Publicado: (2021)

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
por: Sandahl, Mads, et al.
Publicado: (2022)

Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment
por: Da Rosa, M.R., et al.
Publicado: (2011)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
por: Press, Benjamin H., et al.
Publicado: (2022)

Quantifying the Effect of Location Matching on Accuracy of Multiparametric Magnetic Resonance Imaging Prior to Prostate Biopsy—A Multicentre Study
por: Gavin, Dominic James, et al.
Publicado: (2020)

Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method
por: Thurtle, D, et al.
Publicado: (2018)

Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
por: Liang, Linghui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jld7f3gf2e2tprh0cso28ljh2b